france

Singapore no. 1 in global competition for talent

FONTAINEBLEAU, France and SINGAPORE and SAN FRANCISCO, Nov. 26, 2025 /PRNewswire/ -- Singapore has leapfrogged Switzerland to take top spot…

1 month ago

Valneva Announces Positive Final Phase 2 Results for Lyme Disease Vaccine Candidate

Antibody levels remained well above baseline across all six serotypes and age groups sixth month after third yearly booster doseNo…

1 month ago

Tageos Launches New NFC and Dual-Frequency RFID Inlays for Enhanced Consumer Engagement and Anti-Tamper Applications

The company's two new products—the EOS-920 and the EOS-620 Seal—are designed to meet the evolving needs of a wide range…

2 months ago

GENESIS EMBARKS ON A NEW DECADE WITH LUXURY HIGH PERFORMANCE

Brand announces its direction for the next 10 years by unveiling a new vision centred on “Luxury High Performance”GV60 Magma…

2 months ago

GENESIS UNVEILS MAGMA GT CONCEPT, SIGNALLING THE FUTURE OF ITS PERFORMANCE HERITAGE

Magma GT Concept makes world premiere as the symbolic foundation of Genesis’ next decade of performanceFirst pure sportscar typology from…

2 months ago

Kias PV5 wins the 2026 International Van of the Year

A debut and a win: Kia’s first fully electric van, the PV5, claims the industry’s most prestigious LCV awardUnanimously chosen…

2 months ago

Kia unveils PV5 Chassis Cab and the Kia Business Solutions Ecosystem at SOLUTRANS 2025: a new benchmark for modular electric vans

Kia further expands its Platform Beyond Vehicle (PBV) strategyThe PV5 Chassis Cab’s modular, sub-five-metre design offers payloads up to 1,005…

2 months ago

GMR001 HYPERCAR TESTING REACHES NEW PHASE WITH FIRST PERFORMANCE AND WET WEATHER RUNNING

Testing of the GMR-001 Hypercar entered a new phase last week at Circuit Magny-Cours in France where Genesis Magma Racing…

2 months ago

GENFIT Enters Research Collaboration with EVerZom to Advance Exosome-based Regenerative Technology in ACLF

EVerZom’s investigational drug candidate EViv, developed to treat ACLF, using its proprietary exosome platform, represents a novel approach to regenerative…

2 months ago

GENFIT Presents Promising New Preclinical Data on NTZ/G1090N for the Treatment of ACLF at The Liver Meeting 2025

Preclinical studies demonstrated significant efficacy on systemic inflammation and organ function in ACLF disease modelsSafety data from Phase 1 on…

2 months ago